Publications by authors named "Fatima Miraj"

Lady health workers (LHWs) provide lifesaving maternal and child health services to >60% of Pakistan's population but are poorly compensated and overburdened. Moreover, LHWs' training does not incorporate efforts to nurture attributes necessary for equitable and holistic healthcare delivery. We developed an interdisciplinary humanities curriculum, deriving its strengths from local art and literature, to enhance character virtues such as empathy and connection, interpersonal communication skills, compassion and purpose among LHWs.

View Article and Find Full Text PDF

Background: Gaps in information access impede immunization uptake, especially in low-resource settings where cutting-edge and innovative digital interventions are limited given the digital inequity. Our objective was to develop an Artificially Intelligent (AI) chatbot to respond to caregiver's immunization-related queries in Pakistan and investigate its feasibility and acceptability in a low-resource, low-literacy setting.

Methods: We developed Bablibot (Babybot), a local language immunization chatbot, using Natural Language Processing (NLP) and Machine Learning (ML) technologies with Human in the Loop feature.

View Article and Find Full Text PDF
Article Synopsis
  • Furan chalcone compounds are a promising class of heterocyclic compounds with various therapeutic applications, particularly in medicine and pharmacology.
  • This research involved synthesizing twelve new and seven previously reported furan chalcone derivatives using microwave-assisted methods, exhibiting high yields and followed by testing for their effectiveness as urease enzyme inhibitors.
  • Results showed that certain furan chalcone derivatives demonstrated stronger urease inhibition than the reference drug thiourea, with some having impressive IC values, indicating potential as lead compounds for future drug development against urease-related conditions.*
View Article and Find Full Text PDF

Auto-disable (AD) syringes are specifically designed to prevent syringe reuse. However, the notion that specific AD syringe designs may be unsafe due to reuse concerns related to the syringe's activation point has surfaced. We conducted a systematic review for evidence on the association between AD syringe design and syringe reuse, adverse events following immunization (AEFI), or blood borne virus (BBV) transmission.

View Article and Find Full Text PDF